GC Biopharma Corp. (KRX:006280)
South Korea flag South Korea · Delayed Price · Currency is KRW
127,200
+1,900 (1.52%)
At close: May 30, 2025, 3:30 PM KST

GC Biopharma Revenue

GC Biopharma had revenue of 383.78B KRW in the quarter ending March 31, 2025, with 7.56% growth. This brings the company's revenue in the last twelve months to 1.71T, up 4.46% year-over-year. In the year 2024, GC Biopharma had annual revenue of 1.68T with 3.27% growth.

Revenue (ttm)
1,706.86B
Revenue Growth
+4.46%
P/S Ratio
0.85
Revenue / Employee
849.61M
Employees
2,009
Market Cap
1,451.76B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241,679.89B53.25B3.27%
Dec 31, 20231,626.64B-84.67B-4.95%
Dec 31, 20221,711.31B173.49B11.28%
Dec 31, 20211,537.83B33.71B2.24%
Dec 31, 20201,504.12B147.00B10.83%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,898.69B
Celltrion 3,662.23B
ALTEOGEN 151.65B
Yuhan 2,114.76B
SK Biopharmaceuticals 578.00B
HLB Co., Ltd. 74.64B
Peptron 4.30B
PharmaResearch 392.31B
Revenue Rankings